Lars Bergmann

3.8k total citations
117 papers, 2.2k citations indexed

About

Lars Bergmann is a scholar working on Neurology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lars Bergmann has authored 117 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Neurology, 37 papers in Epidemiology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lars Bergmann's work include Parkinson's Disease Mechanisms and Treatments (53 papers), Neurological disorders and treatments (32 papers) and Restless Legs Syndrome Research (21 papers). Lars Bergmann is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (53 papers), Neurological disorders and treatments (32 papers) and Restless Legs Syndrome Research (21 papers). Lars Bergmann collaborates with scholars based in United States, Germany and Italy. Lars Bergmann's co-authors include Jürgen Peters, Eva Kottenberg, Angelo Antonini, Gerd Heusch, Matthias Thielmann, Heinz Jakob, Werner Poewe, T. Heine, Markus Bangerter and Theodor C. Sauer and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lars Bergmann

106 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Bergmann United States	24	701	566	464	291	278	117	2.2k
Gregory M. T. Hare Canada	35	672 1.0×	363 0.6×	486 1.0×	314 1.1×	977 3.5×	121	3.7k
Ran Meng China	26	785 1.1×	662 1.2×	167 0.4×	326 1.1×	174 0.6×	154	2.5k
Éric Heyer United States	29	886 1.3×	606 1.1×	947 2.0×	1.0k 3.5×	639 2.3×	133	3.0k
Blanca Fuentes Spain	32	850 1.2×	1.7k 3.1×	409 0.9×	753 2.6×	351 1.3×	206	3.8k
Ji Man Hong South Korea	29	1.1k 1.6×	1.7k 3.0×	279 0.6×	1.3k 4.5×	396 1.4×	127	3.2k
Joan Martí‐Fàbregas Spain	33	1.2k 1.7×	1.7k 3.0×	557 1.2×	859 3.0×	363 1.3×	183	3.6k
Fenwick T. Nichols United States	31	912 1.3×	1.7k 3.0×	437 0.9×	888 3.1×	258 0.9×	74	5.2k
Gisele Sampaio Silva Brazil	26	1.0k 1.5×	1.8k 3.3×	314 0.7×	818 2.8×	226 0.8×	151	3.3k
Jacob Elkins United States	30	725 1.0×	1.2k 2.0×	562 1.2×	700 2.4×	119 0.4×	75	3.3k
Manuel Rodríguez‐Yáñez Spain	32	577 0.8×	1.1k 1.9×	419 0.9×	520 1.8×	290 1.0×	128	3.0k

Countries citing papers authored by Lars Bergmann

Since Specialization

Citations

This map shows the geographic impact of Lars Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Bergmann more than expected).

Fields of papers citing papers by Lars Bergmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Bergmann. The network helps show where Lars Bergmann may publish in the future.

Co-authorship network of co-authors of Lars Bergmann

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Bergmann. A scholar is included among the top collaborators of Lars Bergmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Bergmann. Lars Bergmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chaudhuri, К. Ray, Manon Bouchard, Rajesh Pahwa, et al.. (2025). Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 12. 100330–100330.

Aldred, Jason, Tove Henriksen, Martin Bouchard, et al.. (2025). Treatment patterns with long-term foslevodopa/foscarbidopa use in Parkinson’s disease. Parkinsonism & Related Disorders. 134. 107598–107598. 1 indexed citations

Malaty, Irene A., Robert A. Hauser, Bruno Bergmans, et al.. (2025). Correlation between sleep and quality of life in people with Parkinson’s disease treated with continuous subcutaneous infusion of foslevodopa/foscarbidopa. Parkinsonism & Related Disorders. 134. 107599–107599. 1 indexed citations

Rump, Katharina, Björn Koos, Tim Rahmel, et al.. (2024). Methazolamide Reduces the AQP5 mRNA Expression and Immune Cell Migration—A New Potential Drug in Sepsis Therapy?. International Journal of Molecular Sciences. 25(1). 610–610. 5 indexed citations

Nowak, Hartmuth, Björn Koos, Katharina Rump, et al.. (2024). Employing artificial intelligence for optimising antibiotic dosages in sepsis on intensive care unit: a study protocol for a prospective observational study (KI.SEP). BMJ Open. 14(12). e086094–e086094. 3 indexed citations

Chaudhuri, К. Ray, Maurizio Facheris, Bruno Bergmans, et al.. (2024). Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa. Movement Disorders Clinical Practice. 11(7). 861–866. 8 indexed citations

Rahmel, Tim, Hartmuth Nowak, Björn Ellger, et al.. (2024). The Association between the rs3747406 Polymorphism in the Glucocorticoid-Induced Leucine Zipper Gene and Sepsis Survivals Depends on the SOFA Score. International Journal of Molecular Sciences. 25(7). 3871–3871.

Aldred, Jason, Tove Henriksen, Martin Bouchard, et al.. (2024). Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease. Parkinsonism & Related Disorders. 122. 106128–106128. 1 indexed citations

Kern, Drew S., Khashayar Dashtipour, Jason Aldred, et al.. (2023). Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance Treatment: Post Hoc Analysis of a Phase 3 Trial (S32.004). Neurology. 100(17_supplement_2).

10.

Rump, Katharina, Lars Bergmann, Hartmuth Nowak, et al.. (2022). Midazolam impacts acetyl—And butyrylcholinesterase genes: An epigenetic explanation for postoperative delirium?. PLoS ONE. 17(7). e0271119–e0271119. 14 indexed citations

11.

Fasano, Alfonso, Victor S.C. Fung, Klaus Seppi, et al.. (2022). Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica. 146(2). 167–176. 7 indexed citations

12.

Antonini, Angelo, Rajesh Pahwa, Per Odin, et al.. (2022). Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries. Neurology and Therapy. 11(1). 303–318. 10 indexed citations

13.

Kovács, Norbert, Lars Bergmann, Esther Cubo, et al.. (2021). Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 9 indexed citations

14.

Aldred, Jason, Norbert Kovács, Francesco E. Pontieri, et al.. (2020). Improvements in Dyskinesia with Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients in a ‘Real-World’ Study: Interim Results of the Multinational DUOGLOBE Study With up to 24 Months Follow-Up (1824). Neurology. 94(15_supplement). 1 indexed citations

15.

Koos, Björn, Matthias Unterberg, Tim Rahmel, et al.. (2019). A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes. PLoS ONE. 14(5). e0217269–e0217269. 10 indexed citations

16.

Rump, Katharina, Matthias Unterberg, Lars Bergmann, et al.. (2016). AQP5-1364A/C polymorphism and the AQP5 expression influence sepsis survival and immune cell migration: a prospective laboratory and patient study. Journal of Translational Medicine. 14(1). 321–321. 27 indexed citations

17.

Poewe, Werner, et al.. (2015). Global Long-term Registry on Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) - Interim Results in a Subgroup of Patients with Dyskinesia at Baseline (P1.192). Neurology. 84(14_supplement). 1 indexed citations

18.

Antonini, Angelo, К. Ray Chaudhuri, Ashley Yegin, Lars Bergmann, & Werner Poewe. (2015). Global Long-Term Registry on Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) - Interim Results on Non-Motor Symptoms (I3-3B). Neurology. 84(14_supplement). 1 indexed citations

19.

Bergmann, Lars, Eva Kottenberg, Philipp Kahlert, et al.. (2009). Anästhesie bei transfemoraler und transapikaler Aortenklappenimplantation. Herz. 34(5). 381–387. 2 indexed citations

20.

Bergmann, Lars & P.S. Mitrou. (1994). Cytokines in cancer therapy. KARGER eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact